NeuroMetrix (NASDAQ:NURO) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened

NeuroMetrix, Inc. (NASDAQ:NURO)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $3.92 and traded as high as $4.40. NeuroMetrix shares last traded at $4.37, with a volume of 11,005 shares.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on NeuroMetrix in a research note on Saturday. They set a “sell” rating for the company.

NeuroMetrix Price Performance

The firm’s 50 day moving average price is $4.05 and its 200-day moving average price is $3.92. The firm has a market cap of $8.91 million, a price-to-earnings ratio of -0.95 and a beta of 2.18.

NeuroMetrix (NASDAQ:NURO) last posted its quarterly earnings results on Tuesday, November 5th. The medical device company reported ($0.75) earnings per share (EPS) for the quarter. NeuroMetrix had a negative return on equity of 42.56% and a negative net margin of 203.71%. The company had revenue of $0.59 million during the quarter. During the same quarter last year, the company earned ($1.66) EPS.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.